LATEST TWEETS - CURATED BY HASH FINANCE

HOTSTOCK (FPSwatchlist) 8 minutes ago
$BTDG The B2 Fighting Series, owned by @b2digitalotc Inc., will expand its operation in 2019 to include holding LIV… https://t.co/TxpKcpRlUc
Recent $COLL technical alerts: New 52 Week Closing Low plus 9 more alerts... https://t.co/oLdrpEKSp2
Collegium Pharmaceutical $COLL Downgraded by Zacks Investment Research to “Sell” https://t.co/TiGEtvYPPV
Collegium Pharmaceutical $COLL Downgraded by Zacks Investment Research to “Sell” https://t.co/XKbAt5t4XQ
Recent $COLL technical alerts: New 52 Week Closing Low plus 9 more alerts... https://t.co/oLdrpEKSp2
Collegium Pharmaceutical $COLL Downgraded by Zacks Investment Research https://t.co/PjNNxFSyf6
Zacks: Brokerages Expect Collegium Pharmaceutical Inc $COLL to Announce -$0.19 Earnings Per Share https://t.co/dSLJvVWvXY #stocks
Collegium Pharmaceutical Inc $COLL Director Sells $281,500.00 in Stock https://t.co/rWSraOBZgt
Collegium Pharmaceutical Inc $COLL Director Sells $281,500.00 in Stock https://t.co/TxKHK3QEww
Collegium Pharmaceutical $COLL Lowered to Sell at BidaskClub https://t.co/5keEWdcn9k
Collegium Pharmaceutical $COLL Lowered to Sell at BidaskClub https://t.co/vjKrToZR2P
Collegium Pharmaceutical $COLL Lowered to Sell at BidaskClub https://t.co/Hv5FeOtgT5
Collegium Pharmaceutical Inc Expected to Post Q2 2019 Earnings of -$0.25 Per Share $COLL https://t.co/MZvUAwZ9aQ
Collegium Pharmaceutical Inc Expected to Post Q2 2019 Earnings of -$0.25 Per Share $COLL https://t.co/3NJBlb01Ap
Collegium Pharmaceutical $COLL Cut to Sell at BidaskClub https://t.co/hfv6Lungcq
Collegium Pharmaceutical $COLL Cut to Sell at BidaskClub https://t.co/bJKrzpENpC
FY2019 EPS Estimates for Collegium Pharmaceutical Inc $COLL Lowered by Gabelli https://t.co/rWg1WlTKzl #stocks
Gabelli Lowers Collegium Pharmaceutical FY2019 Earnings Estimates to ($0.30) EPS (Previously ($0.15)). https://t.co/5fyRhB5Wba $COLL #COLL
Michael Thomas Heffernan Sells 25,000 Shares of Collegium Pharmaceutical Inc $COLL Stock https://t.co/CO7h9NBxOH
William Blair Comments on Collegium Pharmaceutical Inc’s FY2019 Earnings $COLL https://t.co/hNFC7zHMdP
Q4 2019 EPS Estimates for Collegium Pharmaceutical Inc Lowered by William Blair $COLL https://t.co/7RDuulNjY5 #stocks
Collegium Pharmaceutical $COLL Rating Lowered to Sell at BidaskClub https://t.co/5oX1IBTl7x
Collegium Pharmaceutical $COLL Rating Lowered to Sell at BidaskClub https://t.co/MGT4NkNNxo
Q2 2019 Earnings Estimate for Collegium Pharmaceutical Inc Issued By SunTrust Banks $COLL https://t.co/5RYb6nqBYO #stocks
SunTrust Banks Lowers Collegium Pharmaceutical Q2 2019 Earnings Estimates to ($0.25) EPS (Previously ($0.24)).… https://t.co/BSevThiHCR